Ergebnis der Suchanfrage nach Leuchten

Deutsche Post DHL Group

2

PM: LEJ CAMPUS am DHL Drehkreuz Leipzig feierlich eröffnet / PR: LEJ CAMPUS at DHL’s Leipzig hub officially opened

Nichia Corporation

Further victory of Nichia against Everlight’s subsidiary WOFI in patent infringement proceedings in Germany

Munich (ots) - On December 14, 2022, the Düsseldorf Court of Appeal rendered a judgment in an important patent infringement lawsuit initiated by Nichia Corporation (“Nichia“) against WOFI Leuchten Wortmann & Filz GmbH (“WOFI”) in Germany (docket number I-2 U 2/17). The Düsseldorf Court of Appeal confirmed ...

Nichia Corporation

German court confirms damage compensation claim of Nichia in the amount of 3.225 million EUR against Everlight’s subsidiary WOFI

Munich (ots) - On October 31, 2022, the Düsseldorf District Court in Germany announced its judgment in damage compensation proceedings (docket number 4b O 58/21) initiated by Nichia Corporation (“Nichia“) against WOFI Leuchten Wortmann & Filz GmbH (“WOFI”). The Court awarded Nichia damage compensation in ...

Nichia Corporation

Nichia starts enforcement proceedings in Germany against Everlight's subsidiary WOFI as preparatory step for damage award

Munich (ots) - After the final judgment of the Düsseldorf District Court (docket number 4b O 132/16) finding for infringement of YAG patent EP 936 682 (DE 697 02 929) of Nichia Corporation ("Nichia") by WOFI Leuchten Wortmann & Filz GmbH ("WOFI"), Nichia recently requested WOFI to complete its rendering account ...

Nichia Corporation

Final victory of Nichia against Everlight's subsidiary WOFI in an infringement proceeding in Germany concerning Nichia's YAG Patent

Munich (ots) - On October 1, 2018, only a few weeks prior to the oral hearing at the Düsseldorf Court of Appeal in Germany scheduled for 18 October 2018, WOFI Leuchten Wortmann & Filz GmbH ("WOFI") has completely withdrawn its appeal (docket number I-2 U 33/17) against the judgment of the Düsseldorf District Court ...

Boehringer Ingelheim

New Data Demonstrate Efficacy of Two Leading Anti-HIV Treatments

Dublin, Ireland, November 21 (ots/PRNewswire) - - New hope for HIV/AIDS patients: APTIVUS(R) outperforms several commonly prescribed drugs in the protease inhibitor (PI) class DUBLIN, Ireland, November 21 /PRNewswire/ -- - Experts Emphasize Need for Effective Therapy in Response to Increased Prevalence of HIV/AIDS throughout Europe At the 10th European AIDS Clinical Society (EACS) conference, experts ...